Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, ...

A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

Opposition New Democrats continued their coordinated efforts to attack the government over health care, this time focusing on ...

BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious ...

Researchers also found that one in 14 day case surgery patients have new or worse chronic pain within three months of their ...

In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike," talks with doctors about their specialties' biggest ...

For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...

On the 6th, the Department of Urology at the Catholic University of Korea's Seoul St. Mary's Hospital (Professor Lee Ji-yeol) ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being over age 55. And the unfortunate reality is that women are often diagnosed at ...

Deion Sanders hits reset at Colorado without 'Louis Luggage' recruiting strategy originally appeared on The Sporting News.